Alaska Permanent Fund’s Integra LifeSciences IART Stock Holding History

Alaska Permanent Fund’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-53,312	Closed	-$874K	–	203
2025 Q1	$874K	Hold	53,312	–	–	0.01%	356
2024 Q4	$1.21M	Hold	53,312	–	–	0.02%	348
2024 Q3	$969K	Hold	53,312	–	–	0.01%	363
2024 Q2	$1.32M	Buy	53,312 +40,426	+314%	+$1.2M	0.02%	342
2024 Q1	$457K	Buy	+12,886	New	+$515K	0.01%	418

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alaska Permanent Fund's IART Position: Q2 2025 in Review

Alaska Permanent Fund sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 53,312 shares — an estimated $874K sold.

Alaska Permanent Fund first reported a position in IART in Q1 2024 and held it in 5 quarters. The position peaked at $1.32M in Q2 2024. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

Alaska Permanent Fund reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
Alaska Permanent Fund sold 53,312 Integra LifeSciences shares in Q2 2025, an estimated $874K.
Alaska Permanent Fund first reported a position in Integra LifeSciences in Q1 2024 and held it in 5 quarters.
Alaska Permanent Fund's Integra LifeSciences position peaked at $1.32M in Q2 2024.
208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.